Baseline comparison between the surviving patient cohort (n = 22) and the patients with mortality (n = 7) revealed the underlying liver disease was worse in patients who died compared to the survivors, as shown with significantly higher CHILD-PUGH (10.8 ± 1.77 vs. 8.09 ± 2.1; P = 0.005) and MELD (21.9 ± 8.0 vs. 13.4 ± 8.1; P = 0.023) scores, as well as lower albumin (g/dl) at presentation (2.37 ± 0.4 vs. 2.84 ± 0.5; P = 0.045). This evidence concerns the gene ALB and liver disorder.